- 专利标题: Synthesis methods for upadacitinib and intermediate thereof
-
申请号: US17272369申请日: 2019-08-26
-
公开(公告)号: US11926633B2公开(公告)日: 2024-03-12
- 发明人: Peng Wang , Pixu Li , Qiang Wei , Wen Cheng , Hao Wu
- 申请人: SUZHOU PENGXU PHARMATECH CO., LTD
- 申请人地址: CN Suzhou
- 专利权人: SUZHOU PENGXU PHARMATECH CO., LTD
- 当前专利权人: SUZHOU PENGXU PHARMATECH CO., LTD
- 当前专利权人地址: CN Suzhou
- 优先权: CN 1811008444.4 2018.08.31 CN 1811083531.6 2018.09.17
- 国际申请: PCT/CN2019/102443 2019.08.26
- 国际公布: WO2020/043033A 2020.03.05
- 进入国家日期: 2021-03-01
- 主分类号: C07D487/14
- IPC分类号: C07D487/14 ; C07D207/08 ; C07D207/16 ; C07D241/20 ; C07D487/04
摘要:
The present disclosure relates to a JAK inhibitor upadacitinib intermediate and a preparation method therefor, and to a preparation method for a JAK inhibitor upadacitinib. The upadacitinib intermediate of the present application is as shown in Formula (II) or Formula (III),
wherein, R is a protective group of nitrogen atoms, and R1 is an open-chain or cyclic amine group. Compared with the prior art, the method for the synthesis of upadacitinib of the present application, significantly reduces cost, is environmentally-friendly. And the quality of the final product is well controlled.
wherein, R is a protective group of nitrogen atoms, and R1 is an open-chain or cyclic amine group. Compared with the prior art, the method for the synthesis of upadacitinib of the present application, significantly reduces cost, is environmentally-friendly. And the quality of the final product is well controlled.
公开/授权文献
信息查询